Structure of Scheme 2 compounds with their elemental property, docking score, MM-GBSA binding energy (ΔGbind) and enzyme-based inhibition activity. The biological evaluation of enzyme-based inhibitory activity of test compounds at 10 μm concentration was obtained against recombinant human Sirt1, n = 3, and the results were represented as the mean of three independent experimentsa.
Comp. | R | R1 | R2/R3 | Mol. mass | Static docking Sirt1 (kcal mol−1) | IF guided docking Sirt1 | % inhibition at 10 μM Sirt1 | |
---|---|---|---|---|---|---|---|---|
Dock score (kcal mol−1) | ΔGbind (kcal mol−1) | |||||||
13a | –H | –OMe | –H | 375.42 | −7.42 | −6.54 | −47.19 | <30 |
13b | –OMe | –H | 389.44 | −7.64 | −6.18 | −46.74 | <30 | |
13c | –OMe | –H | 465.08 | −5.81 | −7.44 | −40.64 | <30 | |
13d | –OMe | –H | 504.58 | −6.90 | −7.26 | −63.40 | 90.64 | |
13e | –H | –H | –F | 381.37 | −7.50 | −6.36 | −48.85 | <30 |
13f | –H | –F | 395.40 | −7.22 | −6.51 | −48.22 | <30 | |
13g | –H | –F | 471.50 | −5.05 | −7.42 | −52.96 | <30 | |
13h | –H | –F | 510.53 | −7.88 | −7.21 | −60.23 | 89.15 | |
13i | –H | –NO2 | –H | 390.39 | −7.18 | −6.97 | −59.30 | <30 |
13j | –NO2 | –H | 404.42 | −4.52 | −7.70 | −53.11 | <30 | |
13k | –NO2 | –H | 480.51 | −3.68 | −6.27 | −56.01 | <30 | |
13l | –NO 2 | –H | 519.55 | −5.50 | −7.09 | −70.88 | 89.64 | |
Control | Ex527 | −7.78 | −63.58 | 97.73 |
The italicized rows represent the ligands chosen for further studies.